May 11, 2018 — EnvoyAI announced a new integration with Insignia Medical Systems’ InSight PACS (picture archiving and communication system) to provide artificial intelligence (AI)-enhanced imaging workflows to customers. For initial launch in the U.K., this integration provides curated AI content available on the EnvoyAI platform within the PACS environment at multiple integration points. These include AI results viewing directly within the PACS viewer, as well as within the already established Insignia integration with TeraRecon.
The integrations with EnvoyAI and TeraRecon allow hospitals to customize their AI portfolio based on algorithms they can test and consume from within their Insignia PACS, including the utilization of each hospital’s own internally developed algorithms.
The EnvoyAI platform readies the Insignia InSight PACS for the launch of any AI application – starting with the AI content already available on the EnvoyAI Exchange. With recent growth, the EnvoyAI Exchange now offers a total of 53 products from 22 partners, of which 10 have already achieved U.S. Food and Drug Administration (FDA) clearance. The partnership creates added potential for future workflow integrations to TeraRecon’s iNtuition advanced visualization solution already promoted by Insignia, as well as TeraRecon’s new NorthStar AI-results viewer for advanced physician interactions.
The integration will be displayed in the EnvoyAI and TeraRecon booths at the 2018 Society for Imaging Informatics in Medicine (SIIM) Annual Meeting, May 31-June 2 in National Harbor, Md.
For more information: www.terarecon.com, www.envoyai.com, www.insigniamedical.co.uk
July 27, 2026 
